Citation Impact
Citing Papers
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
2002 StandoutScienceNobel
Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy
2012 StandoutScienceNobel
Functional Interaction between SEL-10, an F-box Protein, and the Nuclear Form of Activated Notch1 Receptor
2001 StandoutNobel
Crystal Structure of Murine/Human Ubc9 Provides Insight into the Variability of the Ubiquitin-conjugating System
1997
Identification of a major co-receptor for primary isolates of HIV-1
1996 StandoutNature
Long‐term efficacy of plasma exchange treatment for refractory Kawasaki disease
2011
Receptor-specific Ubiquitination of β-Arrestin Directs Assembly and Targeting of Seven-transmembrane Receptor Signalosomes
2005 StandoutNobel
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
1988 StandoutScience
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
2005 StandoutNobel
Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
2002 StandoutNatureNobel
[40] Use of retroviral vectors for gene transfer and expression
1993
Analysis of the Protein-Coding Content of the Sequence of Human Cytomegalovirus Strain AD169
1990 Standout
Calcineurin Inhibitor Treatment of Intravenous Immunoglobulin–Resistant Kawasaki Disease
2012
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
2016 StandoutNatureNobel
A New Protein Conjugation System in Human
1998 StandoutNobel
Intravenous gamma-globulin treatment and retreatment in Kawasaki disease
1998
The ubiquitin-proteasome proteolytic pathway
1994 StandoutNobel
The NaV1.7 sodium channel: from molecule to man
2012
Infliximab treatment for refractory Kawasaki syndrome
2005
Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin
2000
Randomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki Disease
2007
Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease
2008
Corticosteroids in the treatment of the acute phase of Kawasaki disease
1999
Reshaping human antibodies for therapy
1988 StandoutNatureNobel
Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
2006
RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO
2002 StandoutNature
A Protein Conjugation System in Yeast with Homology to Biosynthetic Enzyme Reaction of Prokaryotes
2000 StandoutNobel
Kawasaki disease in Greek children: a retrospective study
2012
Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
1996 StandoutNature
A High Affinity Binding Site for the HIV-1 Nucleocapsid Protein
1997 StandoutNobel
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
2002 StandoutNature
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
2000 StandoutNobel
The Atg12-Atg5 Conjugate Has a Novel E3-like Activity for Protein Lipidation in Autophagy
2007 StandoutNobel
Corticosteroids in the initial treatment of Kawasaki disease: Report of a randomized trial
2003
Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children
2003
Interaction of Fas(Apo‐1/CD95) with proteins implicated in the ubiquitination pathway
1997
Trafficking Patterns of β-Arrestin and G Protein-coupled Receptors Determined by the Kinetics of β-Arrestin Deubiquitination
2003 StandoutNobel
Plasma exchange for refractory Kawasaki disease
2004
Preferential Interaction of Sentrin with a Ubiquitin-conjugating Enzyme, Ubc9
1997
The strategy of immune globulin resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy
2008
Do College Students Drink More Than Their Non-College-Attending Peers? Evidence From a Population-Based Longitudinal Female Twin Study.
2004
Modification of Ran GTPase-activating Protein by the Small Ubiquitin-related Modifier SUMO-1 Requires Ubc9, an E2-type Ubiquitin-conjugating Enzyme Homologue
1998
HIV as the cause of AIDS
1996 StandoutNobel
A transient three-plasmid expression system for the production of high titer retroviral vectors
1995
Evaluation of the Efficacy of Treatment of Kawasaki Disease before Day 5 of Illness
2004
Retroviral vectors displaying functional antibody fragments
1993 StandoutNobel
The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection
1995
Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease
2007
Ubiquitin-like proteins: new wines in new bottles
2000
Synthetic glycopeptides and glycoproteins as tools for biology
2004 StandoutNobel
Re‐treatment for immune globulin‐resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy
2001
Global quantification of mammalian gene expression control
2011 StandoutNature
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
A ubiquitin-like system mediates protein lipidation
2000 StandoutNatureNobel
Early Lethality, Functional NF-κB Activation, and Increased Sensitivity to TNF-Induced Cell Death in TRAF2-Deficient Mice
1997
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
2004 StandoutNature
Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product
1992
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays
1993
Reshaping Human Antibodies: Grafting an Antilysozyme Activity
1988 StandoutScienceNobel
Degradation of Proteins with Acetylated Amino Termini by the Ubiquitin System
1989 StandoutScienceNobel
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
SUMO—Nonclassical Ubiquitin
2000
The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions
2000
Recognition and management of Kawasaki disease
1999
Regulation of Receptor Fate by Ubiquitination of Activated β 2 -Adrenergic Receptor and β-Arrestin
2001 StandoutScienceNobel
Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome
1990 StandoutScienceNobel
The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme
1998
Biologically active mutants with deletions in the v-mos oncogene assayed with retroviral vectors.
1985
ATG Systems from the Protein Structural Point of View
2009 StandoutNobel
Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis
2012
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation
1998 StandoutScience
Death Receptors: Signaling and Modulation
1998 StandoutScience
Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment
2006
Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector
1986 StandoutNatureNobel
Coupling of Stress in the ER to Activation of JNK Protein Kinases by Transmembrane Protein Kinase IRE1
2000 StandoutScience
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
Kawasaki Disease: A Brief History
2000
Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range
1991
Pathogenesis of human immunodeficiency virus infection
1993
Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions
1996
Initial Intravenous Gammaglobulin Treatment Failure in Kawasaki Disease
2000
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene
1992
Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein
1994
Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.
1988
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Construction and use of a safe and efficient amphotropic packaging cell line
1988
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
The Long-Term Stability of the Human Gut Microbiota
2013 StandoutScience
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
1996 StandoutScience
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
1993
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Corticosteroid Pulse Combination Therapy for Refractory Kawasaki Disease: A Randomized Trial
2011
Longstanding Obliterative Panarteritis in Kawasaki Disease: Lack of Cyclosporin A Effect
2003
Incorporation of pseudorabies virus gD into human immunodeficiency virus type 1 Gag particles produced in baculovirus-infected cells
1995
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity
1990
A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses.
1989
Suppression of TNF-α-Induced Apoptosis by NF-κB
1996 StandoutScience
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
1989 StandoutNobel
Human lymphocyte Hybridomas and Monoclonal Antibodies
1986
Efficient insertion of genes into the mouse germ line via retroviral vectors.
1985
Works of Dowain A. Wright being referenced
Association of Human Fas (CD95) with a Ubiquitin-conjugating Enzyme (UBC-FAP)
1996
Substance use in the US college-age population: differences according to educational status and living arrangement.
1997
Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids
1996
CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2
1997
Amphotropic retrovirus vector system for human cell gene transfer.
1984
Human immunodeficiency virus pseudotypes with expanded cellular and species tropism
1990
Amphotropic Retrovirus Vector System for Human Cell Gene Transfer
1984
Mutations at opposite Ends of the DIII/S4-S5 Linker of Sodium Channel NaV1.7 Produce Distinct Pain Disorders
2010
Four phosphoproteins with common amino termini are encoded by human cytomegalovirus AD169
1988